Tramadol Hydrochloride Extended-Release Tablets 100 mg, 200 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Tablets

Available Strengths: 100 mg, 200 mg, 300 mg

Reference Brands: Ultram(US); Tramacet, Ultracet(EU)

Category: Analgesic

Tramadol Hydrochloride ER inhibits reuptake of serotonin and norepinephrine while activating opioid receptors, reducing pain signals centrally. Benefits include sustained pain relief for moderate to severe pain, improved mobility, and long-lasting analgesia. It offers rapid onset, fewer gastrointestinal side effects, and suitability for chronic pain management when used under supervision.

Product Description:

OpenAI GPT-4o mini Tramadol Hydrochloride ER (Extended-Release) tablets are approved in the US and EU for moderate to severe pain management. In the US, brands like Ryzolt and ConZip are regulated by the FDA, supported by extensive clinical data, and controlled due to dependence risk. In the EU, EMA-regulated products such as Twynsta and generics require comprehensive dossiers demonstrating safety, efficacy, and manufacturing standards. Both regions enforce strict control measures, label warnings, and pharmacovigilance programs for ongoing safety monitoring. We support efficient market access, ensuring adherence to European and American standards for safe, effective pain therapy.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.